Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling

Zhang,Xiangyu; Zhang,Tao; Gao,Fu; Li,Qingle; Shen,Chenyang; Li,Yankui; Li,Wei; Zhang,Xiaoming

doi:10.3892/mmr.2015.4409

Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling

Authors:
- Xiangyu Zhang
- Tao Zhang
- Fu Gao
- Qingle Li
- Chenyang Shen
- Yankui Li
- Wei Li
- Xiaoming Zhang
View Affiliations

Affiliations: Department of Vascular Surgery, Peking University People's Hospital, Beijing 100044, P.R. China, Department of General Surgery, The Second Affiliated Hospital, Tianjin Medical University, Tianjin 300000, P.R. China
Published online on: October 1, 2015 https://doi.org/10.3892/mmr.2015.4409
Pages: 7317-7325
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular remodeling in response to hemodynamic alterations is a physiological process that requires coordinated signaling between endothelial, inflammatory and vascular smooth muscle cells (VSMCs). Extensive experimental and clinical studies have indicated the critical role of the Ras homolog gene family, member A/Rho‑associated kinase (ROCK) signaling pathway in the pathogenesis of cardiovascular disease, where ROCK activation has been demonstrated to promote inflammation and remodeling through inducing the expression of proinflammatory cytokines and adhesion molecules in endothelial cells and VSMCs. However, the role of ROCK in flow‑induced vascular remodeling has not been fully defined. The current study aimed to investigate the effect of the ROCK signaling pathway in flow‑induced vascular remodeling by comparing the responses to partial carotid artery ligation in mice treated with fasudil (a ROCK inhibitor) and untreated mice. Intima‑media thickness and neointima formation were evaluated by morphology. VSMC proliferation and inflammation of the vessel wall were assessed by immunohistochemistry. In addition, the expression levels of ROCK and the downstream effectors of ROCK, myosin light chain (MLC) and phosphorylated‑MLC (p‑MLC), were quantified by western blot analysis. Following a reduction in blood flow, ROCK1 and p‑MLC expression increased in the untreated left common carotid arteries (LCA). Fasudil‑treated mice developed a significantly smaller intima‑media thickness compared with the untreated mice. Quantitative immunohistochemistry of the fasudil‑treated LCA indicated that there was a reduction in proliferation when compared with untreated vessels. There were fewer CD45+ cells observed in the fasudil‑treated LCA compared with the untreated LCA. In conclusion, the expression of ROCK was enhanced in flow‑induced carotid artery remodeling and ROCK inhibition as a result of fasudil treatment may attenuate flow‑induced carotid artery remodeling.

View Figures

View References

1	Davis PH, Dawson JD, Riley WA and Lauer RM: Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study. Circulation. 104:2815–2819. 2001. View Article : Google Scholar : PubMed/NCBI
2	Cheng KS, Mikhailidis DP, Hamilton G and Seifalian AM: A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc Res. 54:528–538. 2002. View Article : Google Scholar : PubMed/NCBI
3	Libby P: Inflammation in atherosclerosis. Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
4	Pasterkamp G, Galis ZS and de Kleijn DP: Expansive arterial remodeling: Location, location, location. Arterioscler Thromb Vasc Biol. 24:650–657. 2004. View Article : Google Scholar : PubMed/NCBI
5	Bobik A and Tkachuk V: Metalloproteinases and plasminogen activators in vessel remodeling. Curr Hypertens Rep. 5:466–472. 2003. View Article : Google Scholar : PubMed/NCBI
6	Korshunov Va and Berk BC: Flow-induced vascular remodeling in the mouse: A model for carotid intima-media thickening. Arterioscler Thromb Vasc Biol. 23:2185–2191. 2003. View Article : Google Scholar : PubMed/NCBI
7	Post MJ, Borst C and Kuntz RE: The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig. Circulation. 89:2816–2821. 1994. View Article : Google Scholar : PubMed/NCBI
8	Wentzel JJ, Gijsen FJ, Stergiopulos N, Serruys PW, Slager CJ and Krams R: Shear stress, vascular remodeling and neointimal formation. J Biomech. 36:681–688. 2003. View Article : Google Scholar : PubMed/NCBI
9	Wang YX, Martin-McNulty B, da Cunha V, Vincelette J, Lu X, Feng Q, Halks-Miller M, Mahmoudi M, Schroeder M, Subramanyam B, et al: Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipo-protein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation. 111:2219–2226. 2005. View Article : Google Scholar : PubMed/NCBI
10	Shimokawa H and Takeshita A: Rho-kinase is an important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol. 25:1767–1775. 2005. View Article : Google Scholar : PubMed/NCBI
11	Noma K, Oyama N and Liao JK: Physiological role of ROCKs in the cardiovascular system. Am J Physiol Cell Physiol. 290:C661–C668. 2006. View Article : Google Scholar : PubMed/NCBI
12	Sato M, Tani E, Fujikawa H and Kaibuchi K: Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 87:195–200. 2000. View Article : Google Scholar : PubMed/NCBI
13	Masumoto A, Mohri M, Shimokawa H, Urakami L, Usui M and Takeshita A: Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina. Circulation. 105:1545–1547. 2002. View Article : Google Scholar : PubMed/NCBI
14	Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, et al: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 389:990–994. 1997. View Article : Google Scholar : PubMed/NCBI
15	Chen Z and Tzima E: PECAM-1 is necessary for flow-induced vascular remodeling. Arterioscler Thromb Vasc Biol. 29:1067–1073. 2009. View Article : Google Scholar : PubMed/NCBI
16	Szendröi M, Labat-Robert J, Godeau G and Robert AM: Immunohistochemical detection of fibronectin using different fixatives in paraffin embedded sections. Pathol Biol (Paris). 31:631–636. 1983.
17	Erami C, Zhang H, Tanoue A, Tsujimoto G, Thomas SA and Faber JE: Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling. Am J Physiol Heart Circ Physiol. 289:H744–H753. 2005. View Article : Google Scholar : PubMed/NCBI
18	Chatzizisis YS and Giannoglou GD: Pulsatile flow: A critical modulator of the natural history of atherosclerosis. Med Hypotheses. 67:338–340. 2006. View Article : Google Scholar : PubMed/NCBI
19	Stone PH, Coskun AU, Yeghiazarians Y, Kinlay S, Popma JJ, Kuntz RE and Feldman CL: Prediction of sites of coronary atherosclerosis progression: In vivo profiling of endothelial shear stress, lumen and outer vessel wall characteristics to predict vascular behavior. Curr Opin Cardiol. 18:458–470. 2003. View Article : Google Scholar : PubMed/NCBI
20	Silver AE and Vita JA: Shear-stress-mediated arterial remodeling in atherosclerosis: too much of a good thing? Circulation. 113:2787–2789. 2006. View Article : Google Scholar : PubMed/NCBI
21	Korshunov VA and Berk BC: Strain-dependent vascular remodeling: The 'Glagov phenomenon' is genetically determined. Circulation. 110:220–226. 2004. View Article : Google Scholar : PubMed/NCBI
22	Korshunov VA, Mohan AM, Georger MA and Berk BC: Axl, a receptor tyrosine kinase, mediates flow-induced vascular remodeling. Circ Res. 98:1446–1452. 2006. View Article : Google Scholar : PubMed/NCBI
23	Phillips JW, Barringhaus KG, Sanders JM, Hesselbacher SE, Czarnik AC, Manka D, Vestweber D, Ley K and Sarembock IJ: Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation. 107:2244–2249. 2003. View Article : Google Scholar : PubMed/NCBI
24	Korshunov VA, Schwartz SM and Berk BC: Vascular remodeling: Hemodynamic and biochemical mechanisms underlying Glagov's phenomenon. Arterioscler Thromb Vasc Biol. 27:1722–1728. 2007. View Article : Google Scholar : PubMed/NCBI
25	Ibrahim J, Miyashiro JK and Berk BC: Shear stress is differentially regulated among inbred rat strains. Circ Res. 92:1001–1009. 2003. View Article : Google Scholar : PubMed/NCBI
26	Matsumoto Y, Uwatoku T, Oi K, Abe K, Hattori T, Morishige K, Eto Y, Fukumoto Y, Nakamura K, Shibata Y, et al: Long-term inhibition of Rho-kinase suppresses neointimal formation after stent implantation in porcine coronary arteries: involvement of multiple mechanisms. Arterioscler Thromb Vasc Biol. 24:181–186. 2004. View Article : Google Scholar
27	Miyata K, Shimokawa H, Kandabashi T, Higo T, Morishige K, Eto Y, Egashira K, Kaibuchi K, Takeshita A, et al: Rho-kinase is involved in macrophage-mediated formation of coronary vascular lesions in pigs in vivo. Arterioscler Thromb Vasc Biol. 20:2351–2358. 2000. View Article : Google Scholar : PubMed/NCBI
28	Pearce JD, Li J, Edwards MS, English WP and Geary RL: Differential effects of Rho-kinase inhibition on artery wall mass and remodeling. J Vasc Surg. 39:223–228. 2004. View Article : Google Scholar : PubMed/NCBI
29	Wu DJ, Xu JZ, Wu YJ, Jean-Charles L, Xiao B, Gao PJ and Zhu DL: Effects of fasudil on early atherosclerotic plaque formation and established lesion progression in apolipoprotein E-knockout mice. Atherosclerosis. 207:68–73. 2009. View Article : Google Scholar : PubMed/NCBI
30	Grimm M, Haas P, Willipinski-Stapelfeldt B, Zimmermann WH, Rau T, Pantel K, Weyand M and Eschenhagen T: Key role of myosin light chain (MLC) kinase-mediated MLC2a phosphorylation in the alpha 1-adrenergic positive inotropic effect in human atrium. Cardiovasc Res. 65:211–220. 2005. View Article : Google Scholar
31	Rajashree R, Blunt BC and Hofmann PA: Modulation of myosin phosphatase targeting subunit and protein phosphatase 1 in the heart. Am J Physiol Heart Circ Physiol. 289:H1736–H1743. 2005. View Article : Google Scholar : PubMed/NCBI
32	Davis JS, Hassanzadeh S, Winitsky S, Lin H, Satorius C, Vemuri R, Aletras AH, Wen H and Epstein ND: The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell. 107:631–641. 2001. View Article : Google Scholar : PubMed/NCBI
33	Wettschureck N and Offermanns S: Rho/Rho-kinase mediated signaling in physiology and pathophysiology. J Mol Med (Berl). 80:629–638. 2002. View Article : Google Scholar
34	Noma K, Rikitake Y, Oyama N, Yan G, Alcaide P, Liu PY, Wang H, Ahl D, Sawada N, Okamoto R, et al: ROCK1 mediates leukocyte recruitment and neointima formation following vascular injury. J Clin Invest. 118:1632–1644. 2008. View Article : Google Scholar : PubMed/NCBI
35	Ming XF, Viswambharan H, Barandier C, Ruffieux J, Kaibuchi K, Rusconi S and Yang Z: Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 22:8467–8477. 2002. View Article : Google Scholar : PubMed/NCBI
36	Ohashi K, Nagata K, Maekawa M, Ishizaki T, Narumiya S and Mizuno K: Rho-associated kinase ROCK activates LIM-kinase 1 by phosphorylation at threonine 508 within the activation loop. J Biol Chem. 275:3577–3582. 2000. View Article : Google Scholar : PubMed/NCBI
37	Davies SP, Reddy H, Caivano M and Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 351:95–105. 2000. View Article : Google Scholar : PubMed/NCBI
38	Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR and Cohen P: The selectivity of protein kinase inhibitors: A further update. Biochem J. 408:297–315. 2007. View Article : Google Scholar : PubMed/NCBI
39	Liao JK, Seto M and Noma K: Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 50:17–24. 2007. View Article : Google Scholar : PubMed/NCBI